1. Home
  2. RCMT vs CRBU Comparison

RCMT vs CRBU Comparison

Compare RCMT & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCMT
  • CRBU
  • Stock Information
  • Founded
  • RCMT 1971
  • CRBU 2011
  • Country
  • RCMT United States
  • CRBU United States
  • Employees
  • RCMT N/A
  • CRBU N/A
  • Industry
  • RCMT Professional Services
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • RCMT Consumer Discretionary
  • CRBU Health Care
  • Exchange
  • RCMT Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • RCMT 172.2M
  • CRBU 188.8M
  • IPO Year
  • RCMT N/A
  • CRBU 2021
  • Fundamental
  • Price
  • RCMT $23.49
  • CRBU $1.95
  • Analyst Decision
  • RCMT Strong Buy
  • CRBU Strong Buy
  • Analyst Count
  • RCMT 2
  • CRBU 4
  • Target Price
  • RCMT $33.50
  • CRBU $8.50
  • AVG Volume (30 Days)
  • RCMT 52.1K
  • CRBU 2.0M
  • Earning Date
  • RCMT 08-06-2025
  • CRBU 08-12-2025
  • Dividend Yield
  • RCMT N/A
  • CRBU N/A
  • EPS Growth
  • RCMT N/A
  • CRBU N/A
  • EPS
  • RCMT 1.74
  • CRBU N/A
  • Revenue
  • RCMT $290,914,000.00
  • CRBU $9,918,000.00
  • Revenue This Year
  • RCMT $16.29
  • CRBU $9.52
  • Revenue Next Year
  • RCMT $6.16
  • CRBU N/A
  • P/E Ratio
  • RCMT $13.53
  • CRBU N/A
  • Revenue Growth
  • RCMT 8.53
  • CRBU N/A
  • 52 Week Low
  • RCMT $13.18
  • CRBU $0.66
  • 52 Week High
  • RCMT $27.24
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • RCMT 39.96
  • CRBU 54.28
  • Support Level
  • RCMT $24.63
  • CRBU $1.90
  • Resistance Level
  • RCMT $26.11
  • CRBU $2.17
  • Average True Range (ATR)
  • RCMT 0.85
  • CRBU 0.23
  • MACD
  • RCMT -0.30
  • CRBU -0.04
  • Stochastic Oscillator
  • RCMT 12.89
  • CRBU 32.70

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: